このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

AREV Life Sciences Global マネジメント

マネジメント基準チェック /14

AREV Life Sciences Global'sの CEO はMike Withrowで、 Oct2018年に任命され、の在任期間は 6.92年です。は、会社の株式の43.44%を直接所有しており、その価値はCA$ 1.24M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と2.5年です。

主要情報

Mike Withrow

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	5yrs
CEOの所有権	43.4%
経営陣の平均在職期間	3.8yrs
取締役会の平均在任期間	2.5yrs

経営陣の近況

Recent updates

How Much Are AREV NanoTec Brands Inc. (CSE:AREV) Insiders Taking Off The Table?

Jan 02

CEO（最高経営責任者

Mike Withrow

5yrs

在職期間

Mr. Michael Withrow, also known as Mike, serves as Director at AREV Life Sciences Global Corp. (formerly known as AREV NanoTec Brands Inc.) (formerly known as AREV Brands International Ltd.) (formerly, ARE...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Michael Withrow	Chairman & CEO	5yrs	データなし	43.44% CA$ 1.2m
Denby Greenslade	Interim CFO	3.8yrs	CA$72.00k	1.15% CA$ 33.0k
Donald Shaxon	Vice President of Marketing	2.8yrs	データなし	データなし

3.8yrs

平均在職期間

経験豊富な経営陣: AREVの経営陣は経験豊富であると考えられます ( 3.8年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Michael Withrow	Chairman & CEO	6.9yrs	データなし	43.44% CA$ 1.2m
Denby Greenslade	Interim CFO	3.8yrs	CA$72.00k	1.15% CA$ 33.0k
Kevin Phelps	Director	2.7yrs	CA$18.24k	データなし
Harold Smith	Member of Scientific Advisory Board	2.3yrs	データなし	データなし
Roscoe Moore	Chairman of Scientific Advisory Board	2.7yrs	データなし	データなし
Douglas Sorocco	Member of Scientific Advisory Board	1.7yrs	データなし	データなし
Uma V. Dhanabalan	Member of Scientific Advisory Board	2.7yrs	データなし	データなし
Jay Noller	Member of Scientific Advisory Board	2.7yrs	データなし	データなし
Richard Van Breemen	Member of Scientific Advisory Board	2.3yrs	データなし	データなし
Allan Echino	Director	1.8yrs	データなし	2.42% CA$ 69.1k
Brian Elliott	Director	1.6yrs	データなし	データなし
Sateesh Apte	Member of Scientific Advisory Board	1.2yrs	データなし	データなし

2.5yrs

平均在職期間

経験豊富なボード: AREVの取締役会は経験豊富ではない ( 2.5年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

AREV Life Sciences Global マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

AREV Life Sciences Global Corp., Annual General Meeting, Apr 05, 2024

No independent directors

No independent directors

No independent directors

AREV Life Sciences Global Corp. Announces the Resignation of Melvin Maxwell from Board

No independent directors

Recent updates

AREV Life Sciences Global Corp., Annual General Meeting, Apr 05, 2024

No independent directors

No independent directors

No independent directors

AREV Life Sciences Global Corp. Announces the Resignation of Melvin Maxwell from Board

No independent directors

Third quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.009 loss in 3Q 2021)

Chairman & CEO recently bought CA$59k worth of stock

No independent directors

AREV Life Sciences Global Corp. Announces Management Changes

Second quarter 2022 earnings released: CA$0.026 loss per share (vs CA$0.028 loss in 2Q 2021)

AREV Life Sciences Global Corp. Announces the Appointment of Sateesh Apte to the Scientific Advisory Board

Full year 2021 earnings released: CA$0.051 loss per share (vs CA$0.068 loss in FY 2020)

No independent directors

AREV Life Sciences Global Corporation Appoints Brian V. Elliott to its Board of Directors

AREV Life Sciences Global Corp. Appoints Kevin Phelps as Chief Operating Officer

AREV Life Sciences Global Corp. Appoints Douglas Sorocco to Its Scientific Advisory Committee

AREV Life Sciences Settles Pending Litigation with Harvey

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

AREV Life Sciences Global Corp. (CNSX:AREV) acquired Wright and Well Essentials Inc. for CAD 0.02 million.

Chairman & CEO exercised options to buy CA$200k worth of stock.

Chairman & CEO recently sold CA$125k worth of stock

Second quarter 2021 earnings released: CA$0.028 loss per share (vs CA$0.017 loss in 2Q 2020)

First quarter 2021 earnings released: CA$0.026 loss per share (vs CA$0.012 loss in 1Q 2020)

AREV NanoTec Brands Inc. Expands Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs

AREV NanoTec Brands Inc. announced that it has received CAD 0.67 million in funding

Arev Nanotec Brands Inc. Appoints Chad S. Johnson, Esq. as Special Counsel for Corporate Development

AREV NanoTec Brands Inc. Announces Addition of Kevin J. Phelps to its Board of Directors

AREV NanoTec Brands Inc. Appoints Dr. Jay Noller to its Scientific Advisory Board

AREV’s Nanotech Initiates Early-Stage Antiviral Photochemistry Derivation Discovery Program for Pandemic Viral Pathogens

New 90-day high: CA$0.42

AREV Appoints Dr. Roscoe Moore to Join the Advisory Board

AREV NanoTec Brands Inc. Corporate Update on Latest Innovation

AREV NanoTec Brands Inc. Appoints Dr. Uma V. A. Dhanabalan as Advisory Board

AREV NanoTec Brands Inc. announced that it expects to receive CAD 0.725 million in funding

AREV NanoTec Brands Inc. announced that it has received CAD 0.1 million in funding from Chiron Partners LLC

How Much Are AREV NanoTec Brands Inc. (CSE:AREV) Insiders Taking Off The Table?

New 90-day high: CA$0.22

Chairman & CEO recently sold CA$261k worth of stock

AREV NanoTec Brands Inc. Receives Its First Trial Run of Its Naturvac Immune Boost

AREV NanoTec Brands Inc. Appoints Don Shaxon to the Position of VP Marketing

First half earnings released

AREV Brands International Ltd. (CNSX:AREV) cancelled the acquisition of 5,300 square foot facility and a 100 acre cannabis and hemp cultivation in California.

AREV NanoTec Brands Inc. announced that it expects to receive CAD 0.16 million in funding

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

マネジメント基準チェック /14